These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 30256440)

  • 1. Osteoprotegerin inhibit osteoclast differentiation and bone resorption by enhancing autophagy via AMPK/mTOR/p70S6K signaling pathway in vitro.
    Tong X; Gu J; Song R; Wang D; Sun Z; Sui C; Zhang C; Liu X; Bian J; Liu Z
    J Cell Biochem; 2019 Feb; 120(2):1630-1642. PubMed ID: 30256440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiosteoclastic bone resorption activity of osteoprotegerin via enhanced AKT/mTOR/ULK1-mediated autophagic pathway.
    Zhao H; Sun Z; Ma Y; Song R; Yuan Y; Bian J; Gu J; Liu Z
    J Cell Physiol; 2020 Mar; 235(3):3002-3012. PubMed ID: 31535378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of AMP-activated protein kinase reverses osteoprotegerin-induced inhibition of osteoclast differentiation by reducing autophagy.
    Tong X; Zhang C; Wang D; Song R; Ma Y; Cao Y; Zhao H; Bian J; Gu J; Liu Z
    Cell Prolif; 2020 Jan; 53(1):e12714. PubMed ID: 31696568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of hormone and cytokine-stimulated osteoclastogenesis and bone resorption by interleukin-4 and interleukin-13 is associated with increased osteoprotegerin and decreased RANKL and RANK in a STAT6-dependent pathway.
    Palmqvist P; Lundberg P; Persson E; Johansson A; Lundgren I; Lie A; Conaway HH; Lerner UH
    J Biol Chem; 2006 Feb; 281(5):2414-29. PubMed ID: 16251181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
    Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
    Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P38 mitogen-activated protein kinase inhibitor, FR167653, inhibits parathyroid hormone related protein-induced osteoclastogenesis and bone resorption.
    Tao H; Okamoto M; Nishikawa M; Yoshikawa H; Myoui A
    PLoS One; 2011; 6(8):e23199. PubMed ID: 21886782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoclast differentiation by RANKL and OPG signaling pathways.
    Udagawa N; Koide M; Nakamura M; Nakamichi Y; Yamashita T; Uehara S; Kobayashi Y; Furuya Y; Yasuda H; Fukuda C; Tsuda E
    J Bone Miner Metab; 2021 Jan; 39(1):19-26. PubMed ID: 33079279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 positively regulates osteoprotegerin-mediated inhibition of osteoclastogenesis by downregulating TSC2-induced autophagy in vitro.
    Tong X; Gu J; Chen M; Wang T; Zou H; Song R; Zhao H; Bian J; Liu Z
    Differentiation; 2020; 114():58-66. PubMed ID: 32771207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regulatory function and mechanism of autophagy on osteoclast].
    Miao JS; Wang XY; Jin HM
    Zhongguo Gu Shang; 2023 Apr; 36(4):357-63. PubMed ID: 37087626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of osteoclast bone resorption activity through osteoprotegerin-induced damage of the sealing zone.
    Song R; Gu J; Liu X; Zhu J; Wang Q; Gao Q; Zhang J; Cheng L; Tong X; Qi X; Yuan Y; Liu Z
    Int J Mol Med; 2014 Sep; 34(3):856-62. PubMed ID: 25017214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Puerarin specifically disrupts osteoclast activation via blocking integrin-β3 Pyk2/Src/Cbl signaling pathway.
    Qiu Z; Li L; Huang Y; Shi K; Zhang L; Huang C; Liang J; Zeng Q; Wang J; He X; Qin L; Wang X
    J Orthop Translat; 2022 Mar; 33():55-69. PubMed ID: 35228997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orcinol Glucoside Improves Senile Osteoporosis through Attenuating Oxidative Stress and Autophagy of Osteoclast via Activating Nrf2/Keap1 and mTOR Signaling Pathway.
    Gong W; Liu M; Zhang Q; Zhang Q; Wang Y; Zhao Q; Xiang L; Zheng C; Zhang Q; Qin L
    Oxid Med Cell Longev; 2022; 2022():5410377. PubMed ID: 35585885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol inhibits autophagy in RANKL-induced osteoclast differentiation through activating the PI3K/AKT/mTOR signaling pathway.
    Jiang C; Wang Y; Zhang M; Xu J
    Mol Biol Rep; 2022 Oct; 49(10):9217-9229. PubMed ID: 35881223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H; Härkönen PL; Väänänen HK; Hentunen TA
    J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin activates AMPK and mTOR to Inhibit RANKL-stimulated osteoclast formation.
    Kim YS; Park BS; Baek HS; Kang HM; Oh JM; Kim IR
    Eur Rev Med Pharmacol Sci; 2023 Sep; 27(18):8795-8811. PubMed ID: 37782190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
    Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
    J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRAF6/ERK/p38 pathway is involved in interleukin-17-mediated autophagy to promote osteoclast precursor cell differentiation.
    Shen Y; Wang Z; Tan J; Zhong J; Chen L
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Apr; 50(2):162-170. PubMed ID: 34137231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoralen and Bakuchiol Ameliorate M-CSF Plus RANKL-Induced Osteoclast Differentiation and Bone Resorption Via Inhibition of AKT and AP-1 Pathways in Vitro.
    Chai L; Zhou K; Wang S; Zhang H; Fan N; Li J; Tan X; Hu L; Fan X
    Cell Physiol Biochem; 2018; 48(5):2123-2133. PubMed ID: 30110702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoprotegerin-Knockout Mice Developed Early Onset Root Resorption.
    Liu Y; Du H; Wang Y; Liu M; Deng S; Fan L; Zhang L; Sun Y; Zhang Q
    J Endod; 2016 Oct; 42(10):1516-22. PubMed ID: 27663616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.